COM:AONCOLOGY
American Oncology Network
- Stock
Last Close
4.20
22/11 20:00
Market Cap
14.29M
Beta: -
Volume Today
467
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | 17.26M - | 35.50M 105.64% | 40.52M 14.14% | ||
average payables | 46.45M - | 99.70M 114.62% | 117.07M 17.42% | ||
average receivables | 69.06M - | 152.11M 120.26% | 165.56M 8.85% | ||
book value per share | -0.00 - | -0.00 2,403.30% | -1.49 67,932.70% | ||
capex per share | -1.28 - | -0.87 31.90% | -0.75 13.57% | ||
capex to depreciation | -3.34 - | -1.37 59.05% | -0.42 69.24% | -0.73 74.27% | |
capex to operating cash flow | -0.33 - | 0.32 196.30% | 1.06 235.57% | 0.68 36.06% | |
capex to revenue | -0.02 - | -0.01 47.71% | -0.01 29.05% | -0.01 53.47% | |
cash per share | 2.87 - | 3.86 34.45% | |||
days of inventory on hand | 14.56 - | 12.63 13.24% | 13.60 7.67% | ||
days payables outstanding | 39.17 - | 36.87 5.86% | 38.94 5.62% | ||
days sales outstanding | 53.42 - | 52.73 1.28% | 47.09 10.70% | ||
debt to assets | 0.26 - | 0.39 51.91% | 0.34 12.06% | ||
debt to equity | -3.05K - | -8.95 99.71% | -0.79 91.13% | ||
dividend yield | |||||
earnings yield | 0.24 - | -0.00 100.47% | 0.03 2,492.11% | ||
enterprise value | 91.51M - | 129.28M 41.27% | 196.00M 51.61% | 99.79M 49.09% | |
enterprise value over ebitda | 3.53 - | 16.46 366.65% | 8.49 48.43% | 382.32 4,403.76% | |
ev to operating cash flow | 2.46 - | -4.91 299.78% | -28.89 488.60% | -5.51 80.94% | |
ev to sales | 0.13 - | 0.14 8.49% | 0.17 24.45% | 0.08 54.24% | |
free cash flow per share | 2.63 - | -3.64 238.51% | -1.47 59.67% | ||
free cash flow yield | 0.27 - | -0.37 236.38% | -0.15 60.88% | ||
graham net net | -0.00 - | -4.25 389,564.62% | -8.88 108.70% | ||
graham number | 0.07 - | 0.02 65.40% | 3.02 12,851.80% | ||
income quality | 1.70 - | 250.84 14,683.59% | -2.62 101.04% | 0.29 110.95% | |
intangibles to total assets | 0 - | 0.00 Infinity% | 0.00 15.81% | 0.00 12.88% | |
interest coverage | 19.78 - | 0.64 96.75% | 1.63 153.72% | -7.66 570.25% | |
interest debt per share | 0.12 - | 6.83 5,734.50% | 13.69 100.49% | ||
inventory turnover | 25.07 - | 28.90 15.26% | 26.84 7.12% | ||
invested capital | -3.05K - | -8.95 99.71% | -0.79 91.13% | ||
market cap | 91.51M - | 92.94M 1.56% | 95.80M 3.08% | ||
net current asset value | -10.41K - | 19.52M 187,703.31% | -22.19M 213.68% | -90.92M 309.69% | |
net debt to ebitda | 4.63 - | 4.34 6.22% | 382.32 8,709.72% | ||
net income per share | 2.30 - | -0.01 100.48% | 0.27 2,565.71% | ||
operating cash flow per share | 3.91 - | -2.76 170.72% | -0.71 74.24% | ||
payables turnover | 9.32 - | 9.90 6.23% | 9.37 5.32% | ||
receivables turnover | 6.83 - | 6.92 1.30% | 7.75 11.98% | ||
research and ddevelopement to revenue | |||||
return on tangible assets | 2.29K - | -0.00 100.00% | 0.01 1,975.37% | -0.01 286.40% | |
revenue per share | 76.03 - | 99.00 30.22% | 120.61 21.82% | ||
roe | -26.32K - | 5.03 100.02% | -0.18 103.62% | 0.03 118.80% | |
roic | -27.44K - | -0.00 100.00% | -13.78 325,563.06% | -3.46 74.87% | |
sales general and administrative to revenue | 0.06 - | 0.08 34.37% | 0.08 4.23% | 0.08 0.70% | |
shareholders equity per share | -0.00 - | -0.00 2,403.30% | -1.49 67,932.70% | ||
stock based compensation to revenue | 0.00 - | 0.00 23.21% | -0.00 2,956.67% | 0.00 729.39% | |
tangible asset value | -834 - | 58.43M 7,006,335.01% | 60.79M 4.03% | 4.50M 92.60% | |
tangible book value per share | -0.00 - | 6.25 7,139,668.35% | 6.51 4.15% | ||
working capital | -10.41K - | 88.93M 854,731.94% | 101.08M 13.66% | 108.76M 7.59% |
All numbers in (except ratios and percentages)